Pharmacists in Norfolk, VA Accepting Medicare
190 Pharmacists found. Showing 181 - 190
 Dr. Jennifer Riveros, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Gresham Dr Ste 104, Norfolk, VA 23507 Phone: 757-622-0222 |
 Horace Danny Alexander, BS PHARMACY Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1035 Nider Blvd, Suite 100, Norfolk, VA 23521 Phone: 757-314-7494 Fax: 757-314-7453 |
Bernardita Walsh, BS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1035 Nider Blvd, Suite 100, Norfolk, VA 23521 Phone: 757-314-7391 |
Dr. Tonya Marie Price, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 150 Kingsley Ln, Norfolk, VA 23505 Phone: 757-889-5204 Fax: 757-889-5312 |
Mr. Lewis Hulon Tharp Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7912 Halprin Dr, Norfolk, VA 23518 Phone: 757-588-2007 Fax: 757-531-1461 |
Parulben K Bhatt Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 770 W 21st St, Norfolk, VA 23517 Phone: 757-627-5588 |
Dr. Marian Beshara Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 972 E Little Creek Rd, Norfolk, VA 23518 Phone: 757-480-2704 |
Niya Ayala, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 600 Gresham Dr, Norfolk, VA 23507 Phone: 757-388-5143 |
Dr. David J Reid Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3717 Hampton Blvd, Norfolk, VA 23508 Phone: 757-533-9134 Fax: 757-622-2726 |
Mr. Anthony Todd Stainback, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 Gresham Drive, Norfolk, VA 23507 Phone: 757-388-1204 Fax: 757-388-1202 |
News Archive
Lung ultrasounds can predict outcomes in COVID-19 patients
For some, COVID-19 can result in severe pneumonia or even death, while others remain purely asymptomatic. A diagnostic tool could help physicians predict if a patient with COVID-19 will worsen.
Researchers identify new genetic biomarkers that predict outcomes for patients with bowel cancer
Researchers at University of Limerick and University Hospital Limerick have identified several new genetic biomarkers which better predict outcomes for patients with bowel/colorectal cancer. The research team identified genes that are predictors of cancer recurrence and can also help to identify a patients' suitability to specific types of chemotherapy.
First Australian clinic to exclusively diagnose and treat fetal alcohol spectrum disorders
Australia will soon have its first screening and diagnostic service for children with alcohol-related birth defects. The service is being set up by The Children's Hospital at Westmead in Sydney amid concerns that thousands of Australian children are suffering from fetal alcohol spectrum disorders (FASD). The disorders are triggered in unborn babies exposed to alcohol consumed by their mothers and are the most common, preventable cause of disabilities and brain damage in children.
USPTO issues patent to Synergy's SP-333 for treatment of IBD
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that on February 1, 2011 the U.S. Patent and Trademark Office issued U.S. Patent No. 7,879,802, covering Synergy's novel drug candidate SP-333 to treat inflammatory bowel disease.
Researchers identify a promising model for testing COVID-19 therapeutics
After comparing how infections from SARS-CoV-2 (which causes COVID-19) and two other human coronaviruses develop in cynomolgus macaques, researchers report that SARS-CoV-2 gives the animals a mild COVID-19-like disease.
› Verified 9 days ago
Counselors
Clinical Social Workers
Dentists
Pharmacists
Psychologists
Occupational Therapists